Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible operating margin
Operating margin is operating income as a percentage of revenue.
Skinvisible's operating margin for the twelve months ending Jun 30, 2026 was -2294.9%. For fiscal 2025 it was -2481.6%, against -2947.9% the year before. The highest annual figure on record is 28.3% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2481.6% | +466.4 |
| FY2024 | Dec 31, 2024 | -2947.9% | −496.1 |
| FY2023 | Dec 31, 2023 | -2451.9% | −2366.5 |
| FY2022 | Dec 31, 2022 | -85.4% | −113.7 |
| FY2021 | Dec 31, 2021 | 28.3% | +194.5 |
| FY2020 | Dec 31, 2020 | -166.2% | +1117.0 |
| FY2019 | Dec 31, 2019 | -1283.2% | −420.9 |
| FY2018 | Dec 31, 2018 | -862.2% | −804.3 |
| FY2017 | Dec 31, 2017 | -57.9% | +715.1 |
| FY2016 | Dec 31, 2016 | -773.0% | −154.2 |
| FY2015 | Dec 31, 2015 | -618.7% | +1504.7 |
| FY2014 | Dec 31, 2014 | -2123.4% | −984.6 |
| FY2013 | Dec 31, 2013 | -1138.8% | −649.0 |
| FY2012 | Dec 31, 2012 | -489.8% | +191.8 |
| FY2011 | Dec 31, 2011 | -681.6% | −332.5 |
| FY2010 | Dec 31, 2010 | -349.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2256.3% | +468.4 |
| Q1 FY2026 | Mar 31, 2026 | -2518.8% | +278.3 |
| Q4 FY2025 | Dec 31, 2025 | -2283.4% | +1691.5 |
| Q3 FY2025 | Sep 30, 2025 | -2121.1% | +378.2 |
| Q2 FY2025 | Jun 30, 2025 | -2724.7% | +129.1 |
| Q1 FY2025 | Mar 31, 2025 | -2797.0% | −333.4 |
| Q4 FY2024 | Dec 31, 2024 | -3974.9% | −1244.1 |
| Q3 FY2024 | Sep 30, 2024 | -2499.4% | −237.2 |
| Q2 FY2024 | Jun 30, 2024 | -2853.9% | −597.4 |
| Q1 FY2024 | Mar 31, 2024 | -2463.7% | +94.4 |
| Q4 FY2023 | Dec 31, 2023 | -2730.8% | −376.4 |
| Q3 FY2023 | Sep 30, 2023 | -2262.2% | −897.2 |
| Q2 FY2023 | Jun 30, 2023 | -2256.5% | −2314.8 |
| Q1 FY2023 | Mar 31, 2023 | -2558.1% | −2551.0 |
| Q4 FY2022 | Dec 31, 2022 | -2354.3% | −2409.9 |
| Q3 FY2022 | Sep 30, 2022 | -1365.0% | −442.9 |
| Q4 FY2021 | Dec 31, 2021 | 58.3% | +52.5 |
| Q3 FY2021 | Sep 30, 2021 | -7.0% | +2828.8 |
| Q2 FY2021 | Jun 30, 2021 | 55.6% | +197.4 |
| Q1 FY2021 | Mar 31, 2021 | -922.1% | −112.3 |
| Q4 FY2020 | Dec 31, 2020 | 5.9% | +1094.8 |
| Q3 FY2020 | Sep 30, 2020 | -2835.8% | −1623.5 |
| Q2 FY2020 | Jun 30, 2020 | -141.8% | +962.2 |
| Q1 FY2020 | Mar 31, 2020 | -809.8% | +936.2 |
| Q4 FY2019 | Dec 31, 2019 | -1088.9% | +113.8 |
| Q3 FY2019 | Sep 30, 2019 | -1212.3% | −469.9 |
| Q2 FY2019 | Jun 30, 2019 | -1104.0% | −514.8 |
| Q1 FY2019 | Mar 31, 2019 | -1746.0% | −629.3 |
| Q4 FY2018 | Dec 31, 2018 | -1202.8% | −1250.6 |
| Q3 FY2018 | Sep 30, 2018 | -742.4% | −511.8 |
| Q2 FY2018 | Jun 30, 2018 | -589.3% | +162.2 |
| Q1 FY2018 | Mar 31, 2018 | -1116.7% | +115.9 |
| Q4 FY2017 | Dec 31, 2017 | 47.8% | +645.2 |
| Q3 FY2017 | Sep 30, 2017 | -230.6% | +969.7 |
| Q2 FY2017 | Jun 30, 2017 | -751.5% | −298.2 |
| Q1 FY2017 | Mar 31, 2017 | -1232.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -597.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -1200.3% | – |
| Q2 FY2016 | Jun 30, 2016 | -453.3% | – |
See a number that looks wrong?